.png){kind=icon}
.png){kind=icon}
Return
Pooled Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor, Across Two Phase 3 Trials: CORALreef Lipids and CORALreef HeFH
.png){kind=icon}
PRE
AI
C
E
A
D
E
P
A
S
L
M
S
N
G
J
DOI：10.1016/j.jacl.2026.05.188.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Yes — Merck Sharp & Dohme LLC
Journal
IF:
4.6
Papers:
2.5K
Citations:
4.3K
Organization
No organization information available
Cited Papers